The new general chapter (2.5.42) outlines three procedures for the analysis of N-nitrosamine impurities in active substances.
List view / Grid view
Torrent Pharmaceuticals has received a warning letter from the FDA for violating cGMP regulations at its manufacturing facility in India.
FDA announces the voluntary recall for the losartan medications has been extended to include more lots, after impurities were found in the drugs.
The pharmaceutical company has announced a recall for certain prescription drug bottles which do not meet child-resistant regulations.